Kaiser Permanente Clinical Trials Tool Includes Cost-Effectiveness Modeling
This article was originally published in The Pink Sheet Daily
Executive Summary
The “Archimedes” trial results simulator would allow third-party payors to predict the amount of time before a new drug saves money. Kaiser is spending $17 mil. to develop the model, which could be available at a “non-profit” cost in three years.